Cancer
ROCHESTER, Minn. — A major national cooperative group clinical trial led by Mayo Clinic researchers found that continuing maintenance therapy with lenalidomide beyond two years[...]
Latest stories
AI and Digital Health
January 14, 2025
Neurosciences
January 13, 2025
AI and Digital Health
January 13, 2025
Individualized Medicine
January 9, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community